Please use this identifier to cite or link to this item:
Title: Research And Randomized Clinical Trials During The COVID-19 Pandemic: Could Ethics Guide Us?
Authors: Buruk, Banu
Ekmekci, Perihan Elif
Arda, Berna
Keywords: COVID-19
Randomized Clinical Trials
Institutional Review Boards
Issue Date: 2021
Publisher: William S Hein & Co
Abstract: The COVID-19 disease, was 2020's biggest medical global concern, while peo-ple on earth were experiencing another global concern, climate change. Its fast dissemination has generated the need for randomized clinical trials that adhere to the principles of ethics and are overseen by institutional review boards. Since SARS-CoV-2 is a new virus, a monitored emergency use of unregistered and experimental interventions is inevitably being considered. This study focused on ethical issues of putative COVID-19 therapies during the pandemic and discussed how to address them, to preserve research integrity and the main principles of research ethics. It discussed the critical role of local research institutions and sponsors, research and treatment distinction, the working principles of institutional review boards, obtaining informed consent and also the need for rapid data sharing during the current time-sensitive pandemic circumstances.
ISSN: 0723-1393
Appears in Collections:Temel Tıp Bilimleri Bölümü / Department of Basic Medical Sciences
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record

CORE Recommender

Page view(s)

checked on Feb 6, 2023

Google ScholarTM


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.